P

PCC Rokita SA
WSE:PCR

Watchlist Manager
PCC Rokita SA
WSE:PCR
Watchlist
Price: 67.3 PLN -0.15% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
PCC Rokita SA?
Write Note
Section:
 

Relative Value

The Relative Value of one PCR stock under the Base Case scenario is 89.68 PLN. Compared to the current market price of 67.3 PLN, PCC Rokita SA is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCR Relative Value
Base Case
89.68 PLN
Undervaluation 25%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
28
vs Industry
63
Median 3Y
0.7
Median 5Y
0.7
Industry
1.5
Forward
0.7
More Details
8.4
P/E
P/E
Price to Earnings
8.4
vs History
17
vs Industry
52
Median 3Y
3.8
Median 5Y
6
Industry
21.7
Forward
14.7
More Details
3.6
P/OCF
P/OCF
Price to OCF
3.6
vs History
12
vs Industry
59
Median 3Y
3
Median 5Y
2.9
Industry
13
More Details
12.1
P/FCFE
P/FCFE
Price to FCFE
12.1
vs History
22
vs Industry
3
Median 3Y
7.3
Median 5Y
7.3
Industry
20.5
More Details
1
P/B
P/B
Price to Book Value
1
vs History
68
vs Industry
53
Median 3Y
1.4
Median 5Y
1.4
Industry
1.6
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
49
vs Industry
62
Median 3Y
0.8
Median 5Y
0.9
Industry
1.6
Forward
0.8
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
23
vs Industry
58
Median 3Y
2.6
Median 5Y
3.6
Industry
7.2
More Details
4.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.3
vs History
30
vs Industry
62
Median 3Y
2.9
Median 5Y
4
Industry
13.2
Forward
5
More Details
7.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.7
vs History
28
vs Industry
52
Median 3Y
3.9
Median 5Y
6
Industry
17.5
Forward
11.4
More Details
4.3
EV/OCF
EV/OCF
Enterprise Value to OCF
4.3
vs History
15
vs Industry
58
Median 3Y
3.7
Median 5Y
4.1
Industry
13.9
More Details
7.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.7
vs History
38
vs Industry
28
Median 3Y
5.2
Median 5Y
7.3
Industry
19.1
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
63
vs Industry
55
Median 3Y
1
Median 5Y
1
Industry
1.3
More Details

Multiples Across Competitors

PCR Competitors Multiples
PCC Rokita SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
PCC Rokita SA
WSE:PCR
1.3B PLN 0.7 8.4 4.3 7.7
US
Sherwin-Williams Co
NYSE:SHW
86.3B USD 3.7 33.8 21.8 25.4
US
Ecolab Inc
NYSE:ECL
67.4B USD 4.3 33 21 28.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.1T JPY 4.1 19.7 8.7 11.5
CH
Givaudan SA
SIX:GIVN
36.5B CHF 5.1 35.4 24.7 31.6
US
Dupont De Nemours Inc
NYSE:DD
32B USD 2.6 40.1 12.6 20.9
CN
Wanhua Chemical Group Co Ltd
SSE:600309
232.7B CNY 1.2 15.3 16.7 16.7
US
PPG Industries Inc
NYSE:PPG
27.8B USD 1.5 18.7 11.4 14.1
CH
DSM-Firmenich AG
AEX:DSFIR
26.1B EUR 2.5 12.2 30.9 -60.5
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR 6.3 47.8 32.4 37.6
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
PL
P
PCC Rokita SA
WSE:PCR
Average EV/EBITDA: 19.4
4.3
-19%
N/A
US
Sherwin-Williams Co
NYSE:SHW
21.8
27%
0.8
US
Ecolab Inc
NYSE:ECL
21
38%
0.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
8.7
36%
0.2
CH
Givaudan SA
SIX:GIVN
24.7
34%
0.7
US
Dupont De Nemours Inc
NYSE:DD
12.6
32%
0.4
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.7
131%
0.1
US
PPG Industries Inc
NYSE:PPG
11.4
21%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
30.9
203%
0.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
32.4
10%
3.2
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
PL
P
PCC Rokita SA
WSE:PCR
Average EV/EBIT: 23.2
7.7
-28%
N/A
US
Sherwin-Williams Co
NYSE:SHW
25.4
34%
0.7
US
Ecolab Inc
NYSE:ECL
28.6
52%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.5
N/A N/A
CH
Givaudan SA
SIX:GIVN
31.6
44%
0.7
US
Dupont De Nemours Inc
NYSE:DD
20.9
83%
0.3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.7
39%
0.4
US
PPG Industries Inc
NYSE:PPG
14.1
28%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
Negative Multiple: -60.5 N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
37.6
5%
7.1
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A

See Also

Summary
PCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCR stock valuation using valuation multiples.
Wall Street Estimates
PCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.